Search

everythinglearnresearchcommunity

for

Search:↓

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Birth control pills can cause skin issues but may help with acne and hirsutism, and choosing the right type can minimize side effects.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Combining OMP with cyclosporine can effectively treat severe alopecia areata in children.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Oral contraceptives often cause melasma and other skin issues.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.